Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil TDS vs Morphine Sulfate in Cancer Pain
NCT00943566Phase 2Withdrawn
- Sponsor
- Labtec
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of sufentanil in cancer pain, sponsored by Labtec. Planned start Jan 2010; status: withdrawn.
02
Drugs
sufentanil
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00943566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943566.